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Background: GRIN is an effector of Go/i known to regulate neurite extension.
Results:GRINmodulatesMAPKby sequestering Sprouty, an inhibitor of theMAPKpathway, and this is reversed by active Go
binding.
Conclusion: Activation of Go can inhibit the MAPK pathway by releasing Sprouty from GRIN binding.
Significance: This is a novel mechanism of GPCR regulation of the MAPK pathway.
Go/i interacts directly with GRIN (G protein-regulated
inducer of neurite outgrowth). Using the yeast two-hybrid sys-
tem, we identified Sprouty2 as an interacting partner of GRIN.
Go and Sprouty2 bind to overlapping regions of GRIN, thus
competing for GRIN binding. Imaging experiments demon-
strated that Go expression promoted GRIN translocation to
the plasmamembrane,whereas Sprouty2 expression failed to do
so. Given the role of Sprouty2 in the regulation of growth factor-
mediated MAPK activation, we examined the contribution of
the GRIN-Sprouty2 interaction to CB1 cannabinoid receptor
regulation of FGF receptor signaling. In Neuro-2A cells, a sys-
tem that expresses all of the components endogenously, modu-
lation of GRIN levels led to regulation of MAPK activation.
Overexpression of GRIN potentiated FGF activation of MAPK
and decreased tyrosine phosphorylation of Sprouty2. Pretreat-
ment with Go/i-coupled CB1 receptor agonist attenuated
subsequent FGF activation of MAPK. Decreased expression
of GRIN both diminished FGF activation of MAPK and
blocked CB1R attenuation of MAPK activation. These obser-
vations indicate that Go interacts with GRIN and outcom-
petes GRIN from bound Sprouty. Free Sprouty then in turn
inhibits growth factor signaling. Thus, here we present a
novel mechanism of how Go/i-coupled receptors can inhibit
growth factor signaling to MAPK.
Go, the most abundant G protein in the mammalian brain,
belongs to the Go/i family, containing80% sequence homol-
ogy to Gi1 (1). Go is also expressed in adenohypophysis,
heart, kidney, medulla, olfactory epithelium, and chromaffin
cells (2). Despite its discovery over two decades ago, the direct
signaling partners of Go and effectors are not fully character-
ized. Studies, using yeast two-hybrid screens and cDNAexpres-
sion cloning, have yielded novel direct effectors of Go. They
include the GTPase-activating protein for the small G protein
Rap (RapGAP),3 Gz-GAP (also known as RGS20), the putative
tyrosine phosphatase paladin, the regulator of G protein signal-
ing 17 (RGS-17), the Purkinje cell protein-2 (Pcp2), and the G
protein-regulated inducer of neurite outgrowth (GRIN) (3–5).
The GRIN protein family, consisting of three gene products,
GRIN1–3 (GPRIN1–3), is highly expressed in the brain and
binds selectively to activated forms of Go, Gz, and Gi (5).
GRIN isoforms co-localize with Go at the growth cone of neu-
ronal cells and promote neurite extension in Neuro-2A cells
when co-expressed with the constitutively active mutant Go
Q205L (6). Go-GRIN1 modulates Cdc42 activation and neu-
ronal morphology (6). We have previously identified GRIN3
(originally named IP6) as a direct interacting protein of Go, in
a yeast two-hybrid study using the constitutively active form
Q205L-Go as bait (3). This family member shows sequence
homology to KIAA0514 (amino acids 205–459), which was
later renamed GRIN2 (3, 5).
In the present study, we used the yeast two-hybrid system to
identify potential downstream partners of the Go-GRIN2
pathway. GRIN2 was used as the bait to screen a human brain
cDNA library, and among the candidate proteins hits was
Sprouty2, a known regulator of receptor tyrosine kinase signal-
* This work was supported, in whole or in part, by National Institutes of Health
Grants R01GM54508 (to R. I.) and 5R01DK087650 (to R. I. and S. R. N.) and
RO1 CA59998 (to J. D. L.). This work was also supported by the Systems
Biology Center of New York (Grant PSDGM071558).
□S This article contains supplemental Figs. S1–S3.
1 Supported by the Mount Sinai Medical Scientist Training Program and by a
Cardiovascular Sciences Training Grant HL-07824.
2 To whom correspondence should be addressed: Mount Sinai School of
Medicine, Dept. of Pharmacology and System Therapeutics, One Gustave
L. Levy Place, Box 1215, New York, NY 10029. Tel.: 212-659-1765; Fax: 212-
831-0114; E-mail: Susana.neves@mssm.edu.
3 The abbreviations used are: GAP, GTPase-activating protein; GRIN, G pro-
tein-regulated inducer of neurite outgrowth; bFGF, basic fibroblast growth
factor; NHEI, Na/H exchanger; DMSO, dimethyl sulfoxide; aa, amino
acids; m, mouse; h, human; CB1R, cannabinoid receptor 1.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 287, NO. 17, pp. 13674 –13685, April 20, 2012
© 2012 by The American Society for Biochemistry and Molecular Biology, Inc. Published in the U.S.A.
13674 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287 • NUMBER 17 • APRIL 20, 2012
ing. Sprouty2 has been shown to inhibit both neuronal differ-
entiation and survival through a negative-feedback loop that
down-regulates neurotrophic-driven signals (7, 8). Our results
show that Sprouty2 andGRIN isoforms interact in exogenously
expressed and endogenous systems.We have characterized the
interaction and functional consequence of GRIN in communi-
cating Go signals to Sprouty2. In a fully endogenous system,
activation of Go/1-coupled receptor can inhibit subsequent
stimulation of MAPK1,2 by receptor tyrosine kinase, and thus
theGRIN-Sprouty interaction can serve as a temporal bridge to
connect heterotrimeric receptor G protein pathway regulation
of receptor tyrosine kinase signaling to MAPK1,2.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection—HEK-293T cells were main-
tained in Dulbecco’s modified Eagle’s medium supplemented
with 10% fetal bovine serum and 1% penicillin-streptomycin,
and Neuro-2A cells were maintained in minimum essential
medium supplemented with 10% fetal bovine serum, 2 mM glu-
tamine, 1 mM sodium pyruvate, and 1% penicillin-streptomy-
cin. Neuro-2A cells were obtained from ATCC (CCl-131).
Lipofectamine 2000 (Invitrogen) was used for introduction of
exogenous DNA intoHEK-293T andNeuro-2A cells according
to the manufacturer’s instructions. For HEK-293T cells, 1.8 
106 cells were plated on 60-mm dishes, and 24 h later, the cells
were transfected with 5 g of DNA, or 5.5  106 cells were
plated on 100-mm dishes, and 24 h later, the cells were trans-
fected with 10g of DNA. For imaging experiments, Neuro-2A
cells (1.2  105) were plated on 35-mm MatTek plates and
transfected using Lipofectamine 2000 the following day.
Neuro-2A cells were serum-starved in serum-free media (0.1%
BSA modified Eagle’s medium).
Treatment with Growth Factors or Agonists—Cells were
treated with various growth factors or agonists in culture using
serum-free media. Basic fibroblast growth factor (bFGF, Invit-
rogen) was dissolved in PBS with 0.1% BSA to a stock concen-
tration of 100 ng/ml and stored at 20 °C until use. Epidermal
growth factor (EGF, Millipore) was dissolved in PBS to a stock
concentration of 50 ng/ml and stored at 20 °C. Glial-derived
neurotrophic factor (Promega) was dissolved in PBS at a stock
concentration of 100 ng/ml and stored at 20 °C. HU-210
(Sigma) was dissolved in DMSO at a stock concentration of 10
mM and stored at 80 °C. Carbachol (Tocris) was dissolved in
DMSO.
DNA Constructs—The cDNA clone KIAA0514 was identi-
fied in public databases and was generously supplied by Dr. T.
Nagase (Kazusa DNA Research Institute). This cDNAwas sub-
cloned into various vectors (pPC86 (SalI-NotI), pBk FLAG
(SalI-NotI), pcDNA3.1-HA (EcoRI-NotI), and pGEX4T2 (SalI-
NotI)). Mouse GRIN2 was cloned by one-step RT-PCR
(Qiagen) from mouse whole brain mRNA using the following
primers: 5-ATGAGTTCTAGCCACCCTGAA-3 (forward)
and 5-TCA TTC TGG AGC CGC TCC AGA-3(reverse).
The PCR fragment was then purified and subcloned into
various vectors (pcDNA3.1 using restriction sites HindIII-
EcoRI; pCMV FLAG using restriction sites HindIII-EcoRI;
pcDNA3.1-HA using restriction sites HindIII-NotI; pEGFP N1
using restriction sites BglII-HindIII; and pEGFP C1 using
restriction sites BglII-KpnI). Mouse GRIN2 truncation con-
structs resulting in 1–100, 1–200, and 1–300 amino acids (aa)
were subcloned into pcDNA3.1-HA using the restriction sites
HindIII-NotI. The constructs pcDNA3 Sprouty2, pcDNA3
FLAGmouse Sprouty1, Sprouty2, Sprouty3, and Sprouty4were
described previously (9). Sprouty2 full-length and truncation
constructs (1–295, 1–279, 1–250, 1–238, and 1–209 aa) were
subcloned into pcDNA3.1-HA using the restriction sites Hin-
dIII-NotI, whereas Sprouty2 truncations (1–173 and 174–315
aa) were subcloned into pDsRed-monomer-N1 using the
restriction sites NheI-HindIII. pEGFP N1 Sprouty2 was cloned
using the BglII-HindIII restriction sites. For GST pulldown
constructs, full-length (human) hGRIN2, hGRIN2 1–204, and
hGRIN2 205–461 were cloned into the vector pGEX4T2
(Amersham Biosciences) using the restrictions sites SalI-NotI.
Clones were verified by automated DNA sequencing.
Yeast Two-hybrid Screen—For the yeast two-hybrid study, a
GRIN2 1–360-aa truncation construct was cloned into the
GAL4 DNA activation domain plasmid pPC86 using SalI/NotI
restriction sites and used as the bait to screen a human brain
cDNA library for potential interacting proteins (3).
GST Pulldown—Bacterially expressed purified protein was
bound to glutathione-Sepharose and incubated with HEK-
293T cell lysates expressing pcDNA3 FLAG or pcDNA3 FLAG
human Sprouty2 followed by SDS-PAGE and immunoblotting
with M2-FLAG antibodies.
Co-immunoprecipitation—HEK-293T and Neuro-2A cells
were transfected with the indicated constructs using Lipo-
fectamine 2000. Cells were harvested 48 h later using ice-cold
lysis buffer (1% Triton X-100, 50 mM Tris-HCl, pH 7.5, 10 mM
EDTA, pH 8.0, 150 mM NaCl) supplemented with 1 g/ml
aprotinin, 1 g/ml leupeptin, 1 g/ml pepstatin, 1 mM sodium
orthovanadate, 5 g/ml benzamidine, 5 mM sodium fluoride, 1
mM -glycerophosphate, and 1 mM phenylmethylsulfonyl fluo-
ride). One mg of whole protein was precleared with protein
G-agarose (RocheApplied Science) at 4 °C for 3 h. Immunopre-
cipitations were performed overnight with 4 g of M2-FLAG
(Sigma)monoclonal antibody at 4 °C or 4 g of anti-HAmono-
clonal antibody followed by a 4-h incubation with 30 l of pro-
tein-G agarose. Samples were washed three times with lysis
buffer containing protease inhibitors and then resolved with
SDS-PAGE. After transfer to nitrocellulose, the membranes
were blockedwith 5% nonfat drymilk and immunoblotted with
M2-FLAG, anti-Go, or anti-HA antibodies followed by either
rabbit or mouse TrueBlot (eBioscience) or routine rabbit or
mouse (Pierce) HRP-conjugated secondary antibodies. Whole
cell lysates were resolved on SDS-PAGE, transferred, blocked,
and immunoblottedwith anti-M2-FLAG, anti-Go, or anti-HA
antibodies followed by either rabbit or mouse HRP-conjugated
secondary antibodies (Pierce). Bands were visualized using the
ECL detection method.
RT-PCR—Neuro-2A cells were grown on 100-mm plates to
70% confluency. Total RNAwas isolated using TRIzol (Invitro-
gen) according to the manufacturer’s protocol. One-step RT-
PCR (Qiagen) was used to run PCRs for mouse GRIN2, mouse
GRIN1, mouse Sprouty1,Sprouty2, Sprouty3, and Sprouty4
from Neuro-2A total RNA. The primers used were as follows:
mSprouty1, 5-TACGATTCTGTCCCTAGACC-3 (forward)
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and 5-TATTCCACCATGCTCTCC-3 (reverse); mSprouty2,
5-GATCAGATCAGAGCCATCC-3 (forward) and 5-ACA-
CAGCACACACAAGTCC-3 (reverse); mSprouty3, 5-GCA-
ATGATTATGTGGAACG-3 (forward) and 5-AGGCAGG-
GTAAGAAAAGG-3 (reverse); mSprouty4, 5-ATTGACCA-
GATGAAGACC-3 (forward) and 5-AGTGATAGAAGATA-
CCTTGC-3 (reverse). Each reaction contained 0.6 M of each
gene-specific primer, reaction mix, and 2 g of total RNA. The
annealing temperature was 54 °C, and the extension time
was 40 s.
Real-time RT-PCR—Total RNA was isolated from cells
using TRIZOL reagent (Invitrogen), and real-time RT-PCR
was performed on a LightCycler (Roche Applied Science) using
the QuantiTect SYBR Green RT-PCR system (Qiagen) accord-
ing to the manufacturer’s instructions. Mouse GRIN1
(QT00262136) and tubulin (QT00251664) primer pairs were
purchased fromQiagen from the QuantiTect primer assay col-
lection. Data were analyzed using the LightCycler data analysis
software. Crossing points were calculated using the second
derivative maximummethod. All reactions were done in tripli-
cate, and data for GRIN were normalized against tubulin RNA
levels for each sample.
Antibodies—Antibodies specific for GRIN were made by
immunizing rabbits with a keyhole limpet hemocyanin-conju-
gated peptide specific for GRIN2 (Sigma Genosys). The
sequence for the synthesized peptide for GRIN2 was N-DPEV-
LGVAIQKHLEMQFE-C. Antibodies were affinity-purified on
peptide-conjugated columns (Pierce).
Imaging—Neuro-2A cells were trypsinized and counted 1
day prior to transfection. 5.0  104 cells were plated onto
35-mmMatTek dishes. Cells were transfectedwith the appro-
priate GFP constructs using Lipofectamine 2000 according to
the manufacturer’s instructions. Twenty-four hours after
transfection, living Neuro-2A cells were imaged using a Zeiss
LSM 510 META microscope in an inverted configuration with
a pinhole setting of 1.0 using a UV Plan-Apochromat 63  1.4
NA oil objective and an optical zoom 2 in one x-y focal plane
with the appropriate stage adapter configured for 35-mm
MatTek dishes. Multiple (6–8) 2–5-m Z section slices and
single images were obtained for each sample and condition.
Representative images are shown.
siRNA Knockdown Experiments—Small interfering RNA
smart pool reagents designed for mGRIN1 (catalog number
M-046253-00) and siCONTROL Non-Targeting siRNA pool
(catalog number D-001206-13-05) were purchased fromDhar-
macon. Neuro-2A cells were trypsinized and counted 1 day
prior to transfection. Then, 2.5  105 Neuro-2A cells were
plated onto 35-mm dishes. Twenty-four hours later, cells were
transfected with the appropriate siRNA oligonucleotide (final
concentration 50 nM) using DharmaFECT 2 transfection rea-
gent, according to the manufacturer’s instructions. After 48 h,
one set of cells was trypsinized, split, and plated onto four
35-mmplates at a density of 3.5 104 cells. RNAwas harvested
from a parallel set of transfected cells using the TRIzol method.
Six to eight hours after plating, cells were serum-starved with
FIGURE 1. GRIN proteins interact with Go. A, GST pulldown of GRIN2 and Go. Human GRIN2 1– 461 (FL), 1–204, and 205– 461 were expressed as GST fusion
proteins in bacteria and purified (left panel). GST fusion proteins were incubated with cell lysates from 293T cells exogenously expressing empty vector
(pcDNA3.1) or the constitutively activated Go Q205L (Q/L) mutant and then immunoblotted with Go specific antibodies. Whole cell lysates (WCL) were
immunoblotted for Go expression (right panel). Representative immunoblots (WB) from one of three experiments are shown. B, co-immunoprecipitation of
GRIN2 and Go. HEK-293T lysates were immunoprecipitated (IP) with the M2-FLAG antibody. Immunoprecipitates were resolved by SDS-PAGE and immuno-
blotted with anti-Go antibody and M2-FLAG antibody (left panel). Whole cell lysate was also resolved using SDS-PAGE and immunoblotted with anti-Go
antibody and M2-FLAG antibody (right panel). Representative immunoblots from one of three independent experiments are shown. C, co-immunoprecipita-
tion of GRIN1 and Go. HEK-293T lysate was immunoprecipitated with the M2-FLAG antibody and resolved using SDS-PAGE. Immunoprecipitates were
immunoblotted with anti-Go antibody (panel 1) or M2-FLAG antibody (panel 2). Whole cell lysate was also resolved using SDS-PAGE and immunoblotted with
the anti-Go antibody (panel 3) and M2-FLAG antibody (panel 4). Representative immunoblots from one of two independent experiments are shown. WT, wild
type.
TABLE 1
Results of hGRIN2 (1–360-aa) two-hybrid screen
hGRIN2-interacting protein GenBank accession no. -Gal assay
E2F4 NM_001950 
Nell-2 NM_006159 
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0.1% BSAmodified Eagle’s medium for 16 h. The next day, cells
were stimulated with the appropriate agonist and/or growth
factors for the times indicated. Protein levels of phospho-p44/
42, total p44/42, and tubulin for each sample were determined
by harvesting total cellular lysates followed by separation using
SDS-PAGE and immunoblotting as preciously described.
RESULTS
GRIN Proteins Interact with Go—Our laboratory and others
have found that GRIN isoforms can interact with Go/i (3, 5, 6).
We characterized the nature of the interaction by GST pull-
downs and co-immunoprecipitation assays. To identify the
region on GRIN involved in the interaction with Go, GST
fusion constructs were made with human GRIN2 (hGRIN2)
full-length sequence and with truncated N-terminal region of
hGRIN2 (containing 1–204 aa) and truncated C-terminal
region of hGRIN2 (containing 205–461 aa). The various bacte-
ria-expressed GST-tagged proteins were then incubated with
HEK-293T cell lysates expressing an empty vector (pcDNA3.1)
control or the constitutively active mutant Go Q205A. Only
the GST-hGRIN2 full-length sequence and the GST-hGRIN2
205–461-aa truncation were able to pull down Go Q205A
(Fig. 1A, left panel), suggesting that the C-terminal region of
hGRIN2 is required for the interaction with Go. The interac-
tion of hGRIN2 andGo was confirmed by co-immunoprecipi-
tation of overexpressed FLAG-tagged hGRIN2 andGo Q205L
(Fig. 1B). FLAG-TRAF2, a non-Go interacting protein, failed
to immunoprecipitate Go (Fig. 1B).Whole cell lysates showed
that FLAG-TRAF-2, FLAG-GRIN2, and Go were expressed
accordingly (Fig. 1B, right panel). A GenBankTM search uncov-
ered hGRIN mouse homologs mGRIN1 (long isoform) and
mGRIN2 (short isoform). Although these two isoforms share
only 48% homology at the C-terminal region, both FLAG-
mGRIN1 and FLAG-mGRIN2 interact with Go, as shown by
immunoprecipitation (Fig. 1, B and C).
Sprouty2 Interacts with GRIN—To identify potential interac-
tors of GRIN, a yeast two-hybrid screen was performed using
full-length GRIN2 as bait. This resulted in the induction of
reporter genes in the absence of interacting proteins, suggest-
ing that full-length GRIN2 contains a transcriptional activation
domain (supplemental Fig. S1). To overcome this, we made
truncations of GRIN2 and found that the truncation GRIN2
1–360 was the construct that lacked the transcriptional activa-
tion domain, and thus, we used it as bait in the yeast two-hybrid
study. We screened a human brain cDNA library and found a
number of potential GRIN2 interactors (Table 1). These inter-
FIGURE 2. GRIN proteins associate with Sprouty. A, GST pulldown of
Sprouty2 and GRIN2. Human GRIN2 1– 461 full-length and GST alone were
expressed as GST fusion proteins in bacteria and purified. GST fusion proteins
were bound to glutathione beads and incubated with cell lysates from HEK-
293T cells exogenously expressing empty vector (pcDNA3.1 FLAG (pcDNA3.1
Flg)) or FLAG-hSprouty2 (Flg-hSprouty2). GST-hGRIN2-associated proteins
(left panel) were immunoblotted with M2-FLAG antibodies, whereas HEK-
293T whole cell lysates (WCL, right panel) were immunoblotted with anti-
Sprouty2 antibodies. Representative immunoblots (WB) from one of three
experiments are shown. B, co-immunoprecipitation (IP) of GRIN1 and GRIN2
with Sprouty2. HEK-293T lysate was immunoprecipitated with anti-HA
(12C25) antibody and resolved using SDS-PAGE. Immunoprecipitates were
immunoblotted with M2-FLAG (top left panel) and an anti-HA antibody (bot-
tom left panel). Whole cell lysate was resolved using SDS-PAGE, immuno-
blotted with the M2-FLAG antibody (top right panel), and further blotted with
the anti-HA antibody (bottom right panel). Representative immunoblots from
one of three experiments are shown. Flg, FLAG. C, co-immunoprecipitation of
GRIN2 with Sprouty proteins. HEK-293T cells were transfected with the indi-
cated expression constructs, and total cell lysates were immunoprecipitated
with the M2-FLAG antibody and resolved using SDS-PAGE. M2-FLAG immu-
noprecipitates were immunoblotted with an anti-HA antibody (panel 1) and
with M2-FLAG antibody (panel 2). Whole cell lysates were immunoblotted
with the anti-HA antibody and M2-FLAG antibody. Representative immuno-
blots from one of two experiments are shown.
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actors were confirmed both in growth (on plates lacking leu-
cine, tryptophan, and histidine) and in -gal assay (-galacto-
sidase activity). The first protein identified was E2F4, a known
transcription repressor that has been shown to function in
growth suppression and differentiation (10). E2F4 represses
genes during quiescence, heterodimerizes with p130 after cell
cycle exit, and thereby induces differentiation in developing
neurons (11). A second interactor candidate identifiedwas neu-
ral epidermal growth factor-like like 2 (Nell2). Nell2 is a neu-
ron-specific thrombospondin-1-like extracellular protein con-
taining six epidermal growth factor-like domains that is highly
expressed in the hippocampus (12, 13). Nell2 was found to act
within the CNS and peripheral nervous system progenitors to
promote neuronal differentiation. Nell2/ mice have defects
in spatial learning (14, 15). TheNa/H exchanger (NHEI) was
also identified to directly interact with hGRIN2. NHEI has been
shown to play a major role in intracellular pH homeostasis and
cell volume regulation. Stimulation of NHEI is required for cell
proliferation, and its activity can be modulated by pH, tumor
promoters, growth factors, and cell surface receptor signaling
(16–19). Sprouty2, another direct interacting protein, belongs
to a family of fourmammalian proteins with a conserved C-ter-
minal cysteine-rich domain that has been shown to regulate
tyrosine kinase receptor signaling (20, 21). hSprouty2 and
hGRIN2 direct interaction was confirmed by GST pulldown
(Fig. 2A). Co-transfection of HA-mSprouty2 with mGRIN1 or
mGRIN2 in HEK-293T cells followed by immunoprecipitation
showed that both GRIN isoforms interact with Sprouty2 (Fig.
2B). Of note, Sprouty2 expression appears as a doublet in whole
cell lysate gels, and Sprouty2 expression has been shown by
other groups to exist as a doublet and sometimes triplet due to
serine phosphorylation (22–24). Given their sequence homol-
ogy, other members of the Sprouty family can potentially inter-
act with GRIN2 proteins. We overexpressed FLAG-tagged
mouse Sprouty1, Sprouty2, Sprouty3, and Sprouty4 in conjunc-
tion with control vector (pcDNA3.1) or HA-GRIN2 in 293T
cells. After immunoprecipitating Sprouty proteins and immu-
noblotting for GRIN2, we found that Sprouty1, Sprouty2, and
Sprouty4 were able to interact with GRIN2 whereas Sprouty3
could not (Fig. 2C). Whole cell lysates showed that Sprouty
proteins and GRIN2 proteins were expressed in 293T cells (Fig.
2C, lower panel).
The Conserved C-terminal Domain of Sprouty2 Is Important
for Interaction with GRIN2—To further characterize the
Sprouty2-GRIN interaction, we sought to determine the
regions of Sprouty2 responsible for GRIN2 binding. The ability
of Sprouty to inhibit theMAPK signaling pathway is dependent
on its C terminus (region 295–315 aa) (25). TheC terminus also
contains a dimerization domain (209–238 aa, Fig. 3A). Based
on this, we made several C-terminal truncations of mSprouty2
tagged with hemagglutinin (HA) or DsRed monomer as fol-
lows: HA-Sprouty2 1–315 full-length, HA-Sprouty2 1–295
(1), HA-Sprouty2 1–279 (2), HA-Sprouty2 1–250 (3), HA-
Sprouty2 1–239 (4), HA-Sprouty2 1–209 (5), DsRed mono-
mer N1-Sprouty2 1–73 (6), and DsRed monomer N1
Sprouty2 174–315 (7) (Fig. 3B). We co-expressed these trun-
cations with FLAG-mGRIN2 in HEK-293T cells and immuno-
precipitated with M2-FLAG antibody. The only mSprouty2
truncations detected aftermGRIN2 immunoprecipitationwere
those containing region 250–279 (Fig. 3C). This suggests that
the region of Sprouty2 that interacts with GRIN2 lies in the
C-terminal conserved cysteine region and resides between
amino acids 250–279.
Sprouty2 and Go Compete for GRIN2 Binding—We next set
out to map the regions of GRIN2 necessary for Sprouty2 and
Go binding. We made truncated HA-tagged mGRIN2 vari-
FIGURE 3. The conserved C-terminal domain of Sprouty2 is essential for
GRIN interaction. A, schematic diagram of the Sprouty2. B, constructs used in
these studies and summary of results. C1 to C5 mSprouty2 truncations
were tagged with an HA epitope. Mouse Sprouty2 truncations C6 and C7
were made into fusion proteins with the pDsRed. C, Sprouty2 regions essen-
tial for GRIN2 binding. HEK-293T cells were co-transfected with the indicated
plasmids (C1-C7 and FLAG-mGRIN2) and immunoprecipitated (IP) with
the M2-FLAG antibody. Immunoprecipitates were immunoblotted (WB) with
anti-DsRed (panel 1), anti-HA (panel 2), and M2-FLAG antibodies (panel 3),
respectively. Whole cell lysates (WCL) were also immunoblotted with anti-
DsRed antibody (panel 4), anti-HA antibody (panel 5), and M2-FLAG antibody
(panel 6). Representative immunoblots from one of three independent exper-
iments are shown.
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ants: HA-mGRIN2 and HA-mGRIN2 1–300 (Fig. 4A). A full-
length tagged construct was also made (1–455 aa). The trunca-
tions and the full-length construct were co-expressed with
either Q205L-Go or FLAG-mSprouty2 in HEK-293T cells
followed by immunoprecipitation with anti-HA antibody.
The immunoprecipitate was tested for the presence of Go
or FLAG-mSprouty2. Only full-length HA-mGRIN2 and HA-
mGRIN2 1–300 were able to co-immunoprecipitate Go or
FLAG-mSprouty2. This suggests that the 200–300-aa region of
mGRIN2 is required for Go and Sprouty2 binding.
Because the same region on mGRIN2 is implicated in bind-
ing to Go and Sprouty2, it is possible that these two proteins
compete for GRIN2 binding. To determine whether this was
the case, we set up competitive co-immunoprecipitation exper-
iments. The amount of Go cDNA transfected in Neuro-2A
cells was varied (from 1.5 to 6.0 g), whereas the amount of
FLAG-Sprouty2 (2.0 g) and HA-mGRIN2 cDNA (4.0 g) was
kept constant. GRIN2 was immunoprecipitated and tested for
the presence of Go and FLAG-mSprouty2. Increasing Go
expression led to a decrease in the amount of FLAG-Sprouty2
immunoprecipitated (Fig. 4, B and C). In parallel, we varied the
amount of FLAG-mSprouty2 cDNA transfected (from 2 to 6
g), whereas the amount of Go (1.5g) andHA-mGRIN2 (4.0
g) was kept constant. Similarly to Go, as the expression of
FLAG-mSprouty2 increased, the amount of Go co-immuno-
precipitated decreased (Fig. 4,B andC), suggesting competition
for GRIN binding.
Tyrosine Phosphorylation Modulates Sprouty2-GRIN2 In-
teraction—Sprouty2 has been shown to be tyrosine-phosphor-
ylated, and this phosphorylation is important for its inhibitory
activity of the MAPK pathway (23, 25–27). This tyrosine phos-
phorylation, at Tyr-53, is induced by bFGF signaling (25). We
wanted to determine whether the interaction with GRIN2
affected the tyrosine phosphorylation state of Sprouty2. To do
so, we co-transfected Neuro-2A cells with FLAG-mSprouty2
with vector or mGRIN2. Transfected cells were serum-starved
and then stimulated for 30 min with bFGF in the presence or
absence of a 1-h pretreatment with sodium orthovanadate to
inhibit protein phosphotyrosyl-phosphatases. FLAG-tagged
mSprouty2 was immunoprecipitated with mGRIN2 (Fig. 5A).
Immunoblotting was then performed using anti-phospho-Tyr
antibody (4G10) followed by anti-GRIN and M2-FLAG anti-
bodies. mSprouty is tyrosine-phosphorylated upon bFGF treat-
ment (lanes 1 and 3). mGRIN2 is also tyrosine-phosphorylated
FIGURE 4. Sprouty2 and Go compete for GRIN2 binding. A, the region of 200 –300 aa of GRIN is essential for Sprouty2 and Go binding. Left panel, HEK-293T
cells were co-transfected with the indicated expression constructs, and total cell lysates were prepared as described previously. Lysates were immunoprecipi-
tated (IP) with the anti-Go antibody or with the M2-FLAG antibody and immunoblotted (WB) with the anti-HA antibody (panel 1), with the anti-Go antibody
(panel 2), and with the M2-FLAG antibody (panel 3). Panel 3 contains bands for Go (single band) and FLAG-Sprouty2 (doublet bands). Right panel, whole cell
lysates (WCL) were immunoblotted with the anti-HA antibody (panel 1), with the anti-Go antibody (panel 2), and with the M2-FLAG antibody (panel 3). Panel
3 contains bands for Go (single band) and FLAG-Sprouty2 (doublet bands). Representative immunoblots from one of two independent experiments are
shown. mSp2, mouse Sprouty2; mG2, mouse GRIN2. B, Sprouty2 and Go compete for GRIN2 binding. HEK-293T cells were co-transfected with the indicated
plasmids: Go Q205L (Q/L) mutant (1.5, 3.0, or 6.0 g), FLAG-mSprouty2 (2.0, 4.0, or 6.0 g), and HA-mGRIN2 (4 g). Vector pcDNA3.1 was co-transfected to
make the total amount of DNA transfected equal. Lysates were prepared as described previously and immunoprecipitated with anti-HA antibody. Immuno-
precipitates were immunoblotted with anti-Go (panel 1), M2-FLAG (panel 2), or anti-HA (panel 3) specific antibodies. The triangle indicates increasing concen-
tration of DNA transfected, and the rectangle indicates the same concentration of DNA transfected. A representative blot from three independent experiments
is shown. Lower panel, whole cell lysates were immunoblotted with anti-Go (panel 1), M2-FLAG (panel 2), or anti-HA (panel 3) specific antibodies. Represent-
ative immunoblots from one of three independent experiments are shown. mSpry2; mouse Sprouty2. C, corresponding densitometry for the average of 3– 6
independent experiments testing the following DAN concentrations: Go Q205L (Q/L) mutant (1.5, 3.0, 5.0, or 6.0 g), FLAG-mSprouty2 (2.0, 4.0, 5.0 or 6.0 g),
and HA-mGRIN2 (4 g). AU, arbitrary units. Error bars are S.E.
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in the presence or absence of bFGF. Pretreatment with sodium
orthovanadate enhanced the tyrosine phosphorylation of
mGRIN2 (Fig. 5A, row 1, compare lanes 2 and 6 with lanes 4
and 8). Tyrosine-phosphorylatedmGRIN2 co-immunoprecipi-
tated with FLAG-mSprouty2 irrespective of bFGF stimulation.
On the other hand, when mGRIN2 was co-expressed
with mSprouty2, the amount of tyrosine-phosphorylated
mSprouty2 co-immunoprecipitated decreased (lanes 3 and 4),
suggesting that mGRIN2 co-expression prevents the tyrosine
phosphorylation of mSprouty2. Pretreatment with sodium
orthovanadate shifts up the motility of mSprouty2 band
upward, suggesting furthermodifications (lanes 3 and 7). How-
ever, the amount of tyrosine-phosphorylated mSprouty2 co-
immunoprecipitated decreased in the presence of mGRIN2
even when the cells were treated with sodium orthovanadate
(lanes 7 and 8).Whole cells lysates show that FLAG-mSprouty2
and GRIN2 proteins were expressed similarly (Fig. 5A, lower
panels). Cells treated with bFGF and/or sodium orthovanadate
have higher phosphoERK1/2 levels, indicating that the stimu-
lation and treatment worked as expected (Fig. 5B). The fibro-
blast growth factor (FGF) stimulation of MAPK is damped due
to overexpression of Sprouty.
GRIN2-GFP Fusion Proteins Localize to Plasma Membrane
in Go-expressing Cells but Not Sprouty2-expressing Cells—To
determine whether GRIN2 interaction with Go or Sprouty2
had any effect on GRIN2 localization, we made GRIN2-GFP
fusion proteins. GRIN2 was placed in the N terminus of GFP,
and co-immunoprecipitation experiments showed that this
fusion protein retains the ability to interact with Go and
Sprouty2 (data not shown). We determined the localization of
the GRIN2-GFP construct when co-expressed with Go-
Q205L, Sprouty2, or empty vector expression in Neuro-2A
cells. When overexpressed along with empty vector, GRIN2-
GFP localized to the cytoplasm (Fig. 6, B and E, DIFFUSE).
However, upon expression ofGoQ205L,GRIN2-GFP primar-
ily localized to the plasmamembrane (Fig. 6,C and E, PM). Go
Q205L expression had no effect on enhanced green fluorescent
protein (EGFP) localization (Fig. 6A). This plasma membrane
enrichment was less pronounced with Sprouty2 co-expression
(Fig. 6, D and E, CYTOPM). Sprouty2 localization was not
affected by expression of Go Q205L (supplemental Fig. S2).
Active Go Signaling Attenuates FGF Activation of MAPK—
The previous experiments were performed using exogenous
expression systems. We sought to find a cell line expressing all
three proteins: GRIN, Sprouty2, and Go. Neuro-2A cells
endogenously express GRIN1 and Go (5, 6). Sprouty2 is also
endogenously present in Neuro-2A cells (data not shown).
Sprouty2 has been shown to be regulate growth factor activa-
tion of ERK1/2 (25). The growth factors EGF, FGF, and glial-
derived neurotrophic factor activate MAPK in Neuro-2A cells
(Fig. 7A). Because the GRIN-Sprouty2 interaction can be out-
competed by Go signaling, we determined the functional sig-
nificance of this regulation in the FGF-dependent activation of
MAPK. We used HU-210, a CB1 receptor agonist, to examine
the effects of Go signaling on FGF stimulation ofMAPK path-
way in Neuro-2A cells. Serum-starved Neuro-2A cells were
pretreated with HU-210 (500 nM) for various time periods (15,
30, and 60min) followed by FGF stimulation for 5min. HU-210
pretreatment for 30 or 60 min was able to decrease FGF activa-
tion ofMAPK (Fig. 7, B andC), whereas a 15-min pretreatment
with HU-210 had no effect. Simultaneous co-treatment with
HU-210 and FGF enhanced MAPK activation (Fig. 7B, acute).
This is expected as G subunits fromGo/i can activate MAPK
(28–32). We sought to test whether FGF activation of MAPK
could be repressed by other Go/i-coupled receptors. Pretreat-
ment by carbachol, a muscarinic agonist, also decreased FGF
FIGURE 5. Expression of mGRIN2 inhibits tyrosine phosphorylation of
mSprouty2. A, co-immunoprecipitation of tyrosine-phosphorylated (pY)
GRIN and Sprouty. Neuro-2A cells were transfected with the indicated expres-
sion constructs. Cells were serum-starved overnight. One set of cells was
treated with sodium orthovanadate (1 M) for 1 h prior to stimulation with 40
ng/ml FGF for 30 min as indicated. Total cell lysates were immunoprecipitated
(IP) with M2-FLAG antibody and immunoblotted (WB) with anti-phospho-
tyrosine (G410) (top panel); anti-GRIN antibody (middle panel); and M2-FLAG
antibody (bottom panel). In the whole cell lysate (WCL) panels, whole cell
lysate was immunoblotted with anti-GRIN antibody (panel 1) and M2-FLAG
antibody (panel 2). Of note, the M2-FLAG antibody detected some nonspe-
cific bands (panel 2), and the third band is in fact Sprouty2. mSpry2, mouse
Sprouty2. Na3VO4, sodium orthovanadate. B, whole cell lysates from A were
immunoblotted with anti-phospho-p44/42 ERK1/2 antibody (panel 1), anti-
total p44/42 ERK1/2 antibody (panel 2), and anti-tubulin antibody (panel 3).
Representative immunoblots from one of three independent experiments
are shown.
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activation of MAPK (Fig. 7, D and E), suggesting that this is a
general mechanism not limited to CB1R signaling.
GRIN Potentiates FGF Activation of MAPK—Because
Sprouty2 negatively regulates activation of MAPK, we deter-
mined whether exogenous mGRIN expression could modulate
FGF-mediated MAPK activation. Neuro-2A cells were trans-
fected with vector or FLAG-mGRIN1 or GRIN2. Cells were
then serum-starved for 16 h and stimulated with 20 ng/ml FGF
for 5 min. Expression of either mGRIN1 or mGRIN2 potenti-
ated FGF activation ofMAPK (Fig. 8,A–C). To implicate GRIN
in the HU-210-dependent attenuation of MAPK activation by
FGF, we abolished endogenous mGRIN1 expression using
small interfering RNAs. We hypothesized that by decreasing
GRIN1 levels, we would attenuate FGF activation of MAPK
even further because without GRIN expression, sequestration
and inhibition of Sprouty2 would decrease, and thus, Sprouty2
inhibition of the MAPK pathway would be enhanced.
Neuro-2A cells were transfected with negative control pool
siRNA or mGRIN1 pool siRNA. GRIN1 mRNA was decreased
by 80% after 48 h of transfection with the GRIN1 pool siRNA
(supplemental Fig. S3). siRNA transfected cells were serum-
starved and then pretreated with DMSO or HU-210 (500 nM)
for 30 min followed by FGF stimulation for 5 min. In cells
exposed to mGRIN1 siRNA, pretreatment with HU-210 pro-
duced no difference from DMSO control after 5 min of FGF
stimulation (Fig. 8,D and E). In addition, the levels of phospho-
p44/42 for the GRIN1 siRNA pool decreased when compared
with the negative control pool siRNA. This suggests that
decreasing mGRIN1 expression attenuates FGF activation of
ERK1,2.
DISCUSSION
Our laboratory and others have found GRIN to be a direct
interactor of Go (3, 5, 33). GRIN preferentially interacts with
activatedGo over the wild-type form (Fig. 1C), suggesting that
GRIN proteins may be direct downstream effectors for Go
signaling. GRIN family proteins contain conserved motifs that
are important forGo binding and for Sprouty2 binding. AGo
binding region lies within the semiconserved 200–300-amino
acid region of GRIN2 where Sprouty2 binding occurs as well.
Within this region, there are 15 conserved residues between
GRIN1 andGRIN2, suggesting that these residues are potential
contact sites for Sprouty2 andGo binding.Mutational analysis
and perhaps further truncations within theGRIN2 200–300-aa
region can further define the area of interaction on GRIN2 that
binds Sprouty2 and Go. Similar to GRIN2, GRIN1 has two
established C-terminal binding regions (821–851 and 902–932
aa) for Go (6). Go expression induces the translocation of
GRIN2 from the cytoplasm to the plasma membrane, and the
C-terminal region of GRIN2 is critical for this localization (data
not shown). Similarly, GRIN1has been shown to bemembrane-
bound, and the C-terminal region of GRIN1 (region 772–827)
is required for its localization to the plasma membrane (6). In
fact, two conserved C-terminal cysteine residues, found in
GRINproteins, are required forGRIN1membrane localization.
These two cysteine residues (923–924 aa) are putative palmi-
toylation sites (6) and appear to be conserved in GRIN2. Thus,
it is possible thatGomay induce themembrane recruitment of
GRIN2 by inducing the addition of palmitoyl moieties. Palmi-
toylation, a reversible modification, has been shown to affect
protein activity as well as subcellular localization by changing
the proximity of the protein to its activators and/or targets
(34–37).
The mechanism by which GRIN connects the Go signaling
pathway to the receptor tyrosine kinase-activated MAPK
depends on the ability of GRIN to bind Sprouty. Based on our
results, we propose a modulatory role for GRIN (Fig. 9). In the
absence of Go activity, GRIN binds and sequesters Sprouty (Fig.
9A). GRIN-bound Sprouty is unable to inhibit the MAPK cas-
FIGURE 6. Go expression induces translocation of GRIN2 to plasma membrane. A–D, Neuro-2A cells were transiently transfected with expression plasmids
for pEGFP and Go Q205L (Q/L) mutant (A); GFP-mGRIN2 (B); GFP-mGRIN2 and Go Q205L (C); and GFP-mGRIN2 and Sprouty2 (D). After 24 h, live cells were
imaged in a laser scanning microscope 510-META. Scale bar, 10 m. Representative images from one of four experiments are shown. E, subcellular distribution
of GRIN2-GFP coexpressed with vector (n  137), Go Q205L (n  203), or Sprouty2 (n  53) was scored in Neuro-2A cells as diffuse, cytoplasmic and plasma
membrane-bound (CYTOPM) or mostly plasma membrane-bound (PM). GRIN2 distribution was considered diffuse as shown in the cell marked by a single
arrow in panel B; GRIN2 distribution was considered cytoplasmic and plasma membrane-bound as shown in the cells marked by the double arrow in panel D; and
GRIN2 distribution was considered mostly plasma membrane-bound as shown by the triple arrow in panel C.
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cade. Upon activation of Go, by activation of the CB1R, the
activated Go subunit interacts with GRIN, thus releasing
Sprouty, which can then be activated. Sprouty2 has been shown
to inhibit FGF activation ofMAPK through a number of loci on
the FGF pathway. Sprouty contains a PXXPXRmotif that com-
petes with Sos for binding to the SH3 domain of Grb2 (24). In
addition, phosphorylation of the conserved tyrosines Tyr-55
and Tyr-221 has been shown to be essential for the inhibitory
activity of Sprouty (23, 25, 39). GRIN binds Sprouty within the
region of 250–279 aa. By binding to that region, GRIN may
inhibit Sprouty2 binding of Grb2. GRIN2 expression also
appears to decrease the tyrosine phosphorylation of Sprouty2
after FGF stimulation. In thismodel, Sprouty upon dissociation
from GRIN and activation by tyrosine phosphorylation is able
to inhibit the FGF-ERK1,2 pathway (Fig. 9B). Thus, GRIN func-
tions as a mediator of Go-coupled receptor function to modu-
late the inhibitory effects of Sprouty2 on growth factor stimu-
lation of MAPK activation. This model is supported by our
observation that exogenousGRINexpression inNeuro-2Acells
that have endogenous cannabinoid receptors and FGF receptor
results in potentiation of MAPK activation by FGF stimulation
(Fig. 9), whereas knocking down native GRIN proteins using
siRNA in the same cell line attenuates FGF activation ofMAPK
(Fig. 9).
In examining the potential role of GRIN in neuronal pro-
cesses, GRIN proteins, such as Go, have been implicated in
FIGURE 7. Active Go signaling attenuates FGF signaling. A, Neuro-2A cells express functional FGF receptors. Neuro-2A cells were serum-starved overnight
and then treated with 50 ng/ml EGF, 20 ng/ml FGF, or 20 ng/ml glial-derived neurotrophic factor (GDNF) for various periods of time (0, 2, 5, or 15 min). Western
blots (WB) were performed with monoclonal anti-dual phospho-p44/42 MAPK (top panel), polyclonal anti-dual total p44/42 MAPK (middle panel), and anti-
tubulin antibodies (bottom panel). Representative immunoblots from one of three experiments are shown. B, CB1R prestimulation decreases FGF signaling.
Neuro-2A cells were serum-starved overnight and pretreated with 500 nM HU-210 at different time points (15, 30, and 60 min) followed by stimulation with FGF
for 5 min. Total cell lysate was resolved by immunoblotted with monoclonal anti-dual phospho-p44/42 ERK1/2 (top panel), polyclonal anti-dual total p44/42
ERK1/2 (middle panel), and anti-tubulin antibody (bottom panel). Representative immunoblots from one of three independent experiments are shown. C,
corresponding densitometric data for the average of three independent experiments. Error bars indicate S.E. D, muscarinic receptor prestimulation decreases
FGF signaling. Neuro-2A cells were serum-starved overnight and pretreated with different concentrations of carbachol (500, 250, or 100 nM) at different time
points (30 and 60 min) followed by stimulation with FGF for 5 min. Total cell lysate was immunoblotted with monoclonal anti-dual phospho-p44/42 ERK1/2 (top
panel), polyclonal anti-dual total p44/42 ERK1/2 (middle panel), and anti- tubulin antibody (bottom panel). Representative immunoblots from one of three
independent experiments are shown. E, corresponding densitometric data for the average of three independent carbachol experiments. *, p  0.05. Error bars
indicate S.E.
GRIN Modulates Sprouty Repression of MAPK Activation
13682 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287 • NUMBER 17 • APRIL 20, 2012
FIGURE 8. GRIN expression levels modulate MAPK activation by FGF. A, overexpression of GRIN2 enhances FGF stimulation of MAPK. Neuro-2A cells were
transfected with either pcDNA3.1 (vector control) or pcDNA3.1 mGRIN2. Eight hours after transfection, cells were serum-starved overnight. They were then
treated with FGF (20 ng/ml) for 5 min as indicated. Total cell lysate was immunoblotted (WB) with monoclonal anti-dual phospho-p44/42 ERK1/2 (top panel),
polyclonal anti-dual total p44/42 ERK1/2 (second panel), anti-GRIN (third panel) antibody, and anti-tubulin antibody (bottom panel). Representative immuno-
blots from one of three experiments are shown. B, overexpression of GRIN1 enhances FGF stimulation of MAPK. Neuro-2A cells were transfected with either
pcDNA3.1 FLAG (vector control) or pcDNA3.1 FLAG-mGRIN1. Eight hours after transfection, cells were serum-starved with 0.5% FBS modified Eagle’s medium
for 16 h before stimulation. They were then treated with FGF (40 ng/ml) for 5 min as indicated. Cells were harvested, and 60 g of total cell lysate was resolved
by SDS-PAGE and immunoblotted with monoclonal anti-dual phospho-p44/42 ERK1/2 (top panel), polyclonal anti-dual total p44/42 ERK1/2 (second panel),
M2-FLAG (third panel) antibody, and anti-tubulin antibody (bottom panel). Representative immunoblots from one of three experiments are shown. C, densi-
tometric data for the average of three independent experiments of panel B. Error bars indicate S.E. ns, not significant. D, GRIN1 knockdown attenuates FGF
stimulation of MAPK. Negative pool siRNA and GRIN1-specific siRNA (Dharmacon) were transfected into Neuro-2A cells. Cells were serum-starved overnight
and pretreated with DMSO or HU-210 (500 nM) for 30 min followed by stimulation with FGF (20 ng/ml) for 5 min as indicated. For the acute stimulation, HU-210
(500 nM) and FGF (20 ng/ml) were added simultaneously for 5 min. Whole cell lysate was immunoblotted with monoclonal anti-dual phospho-p44/42 ERK1/2
(top panel), polyclonal anti-dual total p44/42 ERK1/2 (middle panel), and anti-tubulin antibody (bottom panel). Representative immunoblots from one of three
independent experiments are shown. CT, control. E, the corresponding densitometric data for the average of three experimental trials are shown. *, p  0.05.
Error bars indicate S.E.
FIGURE 9. Proposed mechanism of Go-GRIN mediated modulation of Sprouty2 inhibitory effects on MAPK activation. A, in the absence of Hu210, Go is
inactive, and GRIN sequesters Sprouty and prevents it from inhibiting FGF-induced MAPK activation. B, upon stimulation of Go/i-coupled receptors, Go is
activated and binds to GRIN. Sprouty is released and is able to attenuate FGF activated MAPK. Sprouty2 can potentially inhibit at the level of Grb2 and/or at
c-Raf.
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neurite outgrowth (5, 40).Overexpression ofGo andGRIN1 in
Neuro-2A cells resulted in neurite extension, and both proteins
are expressed at the growth cone of neuronal cells (5). GRIN2, a
related family member, is also expressed in the brain, particu-
larly enriched in the cerebellum. Its expression in the neurites
and role in neurite outgrowth is still under investigation. In
addition, Sprouty2 has also been implicated in regulating neu-
rite extension and neuronal development (7, 8, 25, 38, 41).
Expression of a nonphosphorylated Sprouty2 mutant pro-
moted FGF-induced outgrowth of neurites in PC12 cells, thus
suggesting that Sprouty2 negatively regulates neurite out-
growth (9, 25). GRIN2 has been shown to inhibit tyrosine phos-
phorylation of Sprouty2 and thus may be a potential mecha-
nism to negatively regulate Sprouty2 and promote neurite
outgrowth as well. GRIN1 can also interact with Sprouty2 and
perhaps, like GRIN2, may modulate the inhibitory activity of
Sprouty2.
Our laboratory has shown that activation of the Go/i-coupled
cannabinoid CB1 receptors in Neuro-2A promotes the protea-
somal degradation of Rap1GAPII, which subsequently activates
Rap1 to induce neurite outgrowth. Whether Go signaling
through the inhibition of the FGF pathway by GRIN is another
mechanism that promotes neurite outgrowth inNeuro-2A cells
will be addressed in future studies.
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